These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 36774688)
1. Induction of experimental diabetes and diabetic nephropathy using anomer-equilibrated streptozotocin in male C57Bl/6J mice. Kamli-Salino SEJ; Brown PAJ; Haschler TN; Liang L; Feliers D; Wilson HM; Delibegovic M Biochem Biophys Res Commun; 2023 Apr; 650():109-116. PubMed ID: 36774688 [TBL] [Abstract][Full Text] [Related]
2. Can murine diabetic nephropathy be separated from superimposed acute renal failure? Tay YC; Wang Y; Kairaitis L; Rangan GK; Zhang C; Harris DC Kidney Int; 2005 Jul; 68(1):391-8. PubMed ID: 15954931 [TBL] [Abstract][Full Text] [Related]
3. Anomer-equilibrated streptozotocin solution for the induction of experimental diabetes in mice (Mus musculus). de la Garza-Rodea AS; Knaän-Shanzer S; den Hartigh JD; Verhaegen AP; van Bekkum DW J Am Assoc Lab Anim Sci; 2010 Jan; 49(1):40-4. PubMed ID: 20122315 [TBL] [Abstract][Full Text] [Related]
4. Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain. Uil M; Scantlebery AML; Butter LM; Larsen PWB; de Boer OJ; Leemans JC; Florquin S; Roelofs JJTH Sci Rep; 2018 Apr; 8(1):5542. PubMed ID: 29615804 [TBL] [Abstract][Full Text] [Related]
6. IL-17 deficiency aggravates the streptozotocin-induced diabetic nephropathy through the reduction of autophagosome formation in mice. Kim KH; Hong GL; Jung DY; Karunasagara S; Jeong WI; Jung JY Mol Med; 2021 Mar; 27(1):25. PubMed ID: 33691614 [TBL] [Abstract][Full Text] [Related]
7. A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse. Inada A; Kanamori H; Arai H; Akashi T; Araki M; Weir GC; Fukatsu A J Cell Physiol; 2008 May; 215(2):383-91. PubMed ID: 18270980 [TBL] [Abstract][Full Text] [Related]
8. Establishing equivalent diabetes in male and female Nos3-deficient mice results in a comparable onset of diabetic kidney injury. Tian L; Nikolic-Paterson DJ; Tesch GH Physiol Rep; 2019 Sep; 7(18):e14197. PubMed ID: 31535473 [TBL] [Abstract][Full Text] [Related]
10. NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin. Scantlebery AML; Uil M; Butter LM; Poelman R; Claessen N; Girardin SE; Florquin S; Roelofs JJTH; Leemans JC PLoS One; 2019; 14(3):e0214437. PubMed ID: 30908533 [TBL] [Abstract][Full Text] [Related]
11. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway. Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149 [TBL] [Abstract][Full Text] [Related]
12. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy. Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842 [TBL] [Abstract][Full Text] [Related]
13. Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy. Devaraj S; Tobias P; Kasinath BS; Ramsamooj R; Afify A; Jialal I Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1796-804. PubMed ID: 21617141 [TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy. Kitada K; Nakano D; Ohsaki H; Hitomi H; Minamino T; Yatabe J; Felder RA; Mori H; Masaki T; Kobori H; Nishiyama A J Diabetes Complications; 2014; 28(5):604-11. PubMed ID: 24996978 [TBL] [Abstract][Full Text] [Related]
15. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400 [TBL] [Abstract][Full Text] [Related]
16. Protective role of low-dose TGF-β1 in early diabetic nephropathy induced by streptozotocin. Ma X; Ding J; Min H; Wen Y; Gao Q Int Immunopharmacol; 2013 Nov; 17(3):752-8. PubMed ID: 24055008 [TBL] [Abstract][Full Text] [Related]
17. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats. Maheshwari RA; Balaraman R; Sen AK; Seth AK Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335 [TBL] [Abstract][Full Text] [Related]
18. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes. Gross ML; Ritz E; Schoof A; Adamczak M; Koch A; Tulp O; Parkman A; El-Shakmak A; Szabo A; Amann K Lab Invest; 2004 Apr; 84(4):452-64. PubMed ID: 14767489 [TBL] [Abstract][Full Text] [Related]
19. Streptozotocin is equally diabetogenic whether administered to fed or fasted mice. Chaudhry ZZ; Morris DL; Moss DR; Sims EK; Chiong Y; Kono T; Evans-Molina C Lab Anim; 2013 Oct; 47(4):257-65. PubMed ID: 23760565 [TBL] [Abstract][Full Text] [Related]
20. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]